Studies presented at the AMP 2026 Annual Meeting demonstrated artificial intelligence applications for cancer classification, clinical reporting, specimen triage, and ...
A new study reveals that PIK3CA promotes liver tumor growth by helping tumors evade phagocyte-mediated immune responses, suggesting that PIK3CA ...
A new review maps how multigene assays guide breast cancer treatment decisions while flagging critical evidence gaps in node-positive and ...
A five-case series and systematic review of 147 children found that about one in ten deep-seated juvenile xanthogranulomas mimics malignancy ...
CRISPR-engineered cervical cancer cells carrying the PIK3CA-E545K mutation show coordinated immune signaling and metabolic rewiring, driven by suppressed lipid biosynthesis ...
A pharmacoeconomic analysis using Asian cohort data from the INAVO120 trial finds that inavolisib plus palbociclib/fulvestrant is not cost-effective nationally ...
A study of 58 patients found that ovarian cancer ascites-derived cell blocks supported immunohistochemical diagnosis and detected homologous recombination repair ...
In vitro PIK3CA silencing restored anoikis sensitivity and reduced aggressive behaviors in engineered anoikis-resistant rabbit aortic endothelial cells.
An exploratory BRIGHT-2 trial analysis associated longitudinal ctDNA patterns with prognosis, molecular response and candidate resistance alterations in advanced breast ...
A 1,500-patient next-generation sequencing study from Gazi University reveals EGFR and KRAS as dominant drivers in advanced NSCLC, with distinct ...
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!
